Craig Gilgallon
Fondateur chez Cingulate Works, Inc.
Fortune : 6 829 $ au 31/05/2024
Profil
Craig Steven Gilgallon is the founder of Cingulate Works, Inc. (founded in 2013) and Cingulate, Inc. (founded in 2013).
He held the titles of Secretary, Executive VP & General Counsel at both companies.
Mr. Gilgallon is also the founder of Cingulate Therapeutics LLC.
Mr. Gilgallon's current job is as a Partner at Pawar Gilgallon & Rudy LLC (since 2012).
Mr. Gilgallon's education history includes an undergraduate degree from Ithaca College and a graduate degree from Thomas Jefferson School of Law.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CINGULATE, INC.
0,16% | 15/04/2024 | 9 742 ( 0,16% ) | 6 829 $ | 31/05/2024 |
Postes actifs de Craig Gilgallon
Sociétés | Poste | Début |
---|---|---|
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Fondateur | 01/01/2013 |
Pawar Gilgallon & Rudy LLC | Corporate Officer/Principal | 01/01/2012 |
Anciens postes connus de Craig Gilgallon
Sociétés | Poste | Fin |
---|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Fondateur | 15/12/2023 |
CINGULATE INC. | Fondateur | 15/12/2023 |
Formation de Craig Gilgallon
Thomas Jefferson School of Law | Graduate Degree |
Ithaca College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CINGULATE INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
Pawar Gilgallon & Rudy LLC |